Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells.

Source:http://linkedlifedata.com/resource/pubmed/id/17548623

J. Immunol. 2007 Jun 15 178 12 7849-58

Download in:

View as

General Info

PMID
17548623